Presentations & Publications

Presentation

ADXS-PSA immunotherapy increases the magnitude and quality of prostate cancer-antigenspecific T cell responses in patients with metastatic castration-resistant prostate cancer

SITC, November 13, 2017

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases & breaking Advaxis news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.